fusidinsyre/betamethasonvalerat "mylan" 20+1 mg/g creme
mylan ab - betamethasonvalerat, fusidinsyre - creme - 20+1 mg/g
canoderm 5 % creme
aco hud nordic ab - urea - creme - 5 %
daivonex 50 mikrogram/g creme
leo pharma a/s - calcipotriolmonohydrat - creme - 50 mikrogram/g
aldara
viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotika og kemoterapeutiske midler til dermatologisk brug - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.
acivir 50 mg/g creme
stada arzneimittel ag - aciclovir - creme - 50 mg/g
soolantra 10 mg/g creme
galderma nordic ab - ivermectin - creme - 10 mg/g
raft 800 wg vanddispergerbart granulat
bayer a/s - oxadiargyl - vanddispergerbart granulat - 800 g/kg oxadiargyl
nutri-phite magnum s flydende middel
manglende oplysninger - uspecificeret - flydende middel - 0 g/l uspecificeret
axhidrox 2,2 mg/dosis creme
dr. august wolff gmbh & co. kg arzneimittel - glycopyrroniumbromid - creme - 2,2 mg/dosis
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.